SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-048211
Filing Date
2024-11-18
Accepted
2024-11-18 11:47:41
Documents
1
Period of Report
2024-11-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1731948454.html 4  
1 FORM 4 wk-form4_1731948454.xml 4 3873
  Complete submission text file 0001628280-24-048211.txt   5669
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Issuer) CIK: 0000771856 (see all company filings)

IRS No.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address JOHNS HOPKINS UNIVERSITY 720 RUTLAND AVENUE BALTIMORE MD 21205
Business Address
SIDRANSKY DAVID (Reporting) CIK: 0001277161 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-11504 | Film No.: 241470376